PDCD1 and neoplasm: To define the immune mechanisms that contribute to tumor immunity after PD-1 blockade, an in-depth characterization of the TILs by flow cytometry was performed that were isolated from PD-1 Ab-treated, PD-1KO, and PD-1cKO mice.